This inventor holds 1 USPTO granted patent. Top assignee: Scripps Research Institute. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Fabian Pfrengle: Inventor of Antibody–Siglec Ligand Conjugates
Introduction
Fabian Pfrengle is an inventor associated with Klosterneuburg, Austria, and the Scripps Research Institute. His work includes an invention aimed at regulating unwanted immune responses.
Latest Patents
Pfrengle is associated with 1 patent: “Immune Cell Receptor Antibodies Conjugated to High Affinity Siglec-Ligands.” The patent describes Siglec ligand–antibody conjugates and compositions intended to suppress unwanted immune responses, including allergies and anaphylaxis.
Career Highlights
Pfrengle’s listed patent connects antibody-based approaches with high-affinity Siglec ligands, reflecting research focused on immune response regulation. He is associated with the Scripps Research Institute.
Collaborations
His listed coworkers include James C. Paulson and Maidul Islam. Their names are associated with the patent and research context provided.
Conclusion
Fabian Pfrengle’s patent describes a potential approach to suppressing unwanted immune responses by combining antibodies with Siglec ligands.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile